ScreenerHero
RDNTRadNet, Inc.
NAS · US · Healthcare · Diagnostics & Research · radnet.com
76.28USD+0.98%Mkt Cap: 5.94B $P/E: —

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its servic…

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$226.85BUSDP/E 33.1
DAP
Danaher Corporation
$142.58BUSDP/E 38.5
DHR
Danaher Corporation
$151.78BUSDP/E 38.6
LONN
Lonza Group AG
$47.21BUSDP/E 38.3
NTRA
Natera, Inc.
$46.86BUSD
IDXX
IDEXX Laboratories, Inc.
$44.35BUSDP/E 39.5
A
Agilent Technologies, Inc.
$44.14BUSDP/E 31.4
IQV
IQVIA Holdings Inc
$41.03BUSDP/E 31.0
WAT
Waters Corporation
$40.83BUSDP/E 105.8
ILU
Illumina, Inc.
$30.40BUSDP/E 40.4
ILMN
Illumina, Inc.
$30.95BUSDP/E 38.2
MTD
Mettler-Toledo International, Inc.
$28.55BUSDP/E 32.1
LH
Labcorp Holdings Inc.
$26.80BUSDP/E 27.4
DGX
Quest Diagnostics Incorporated
$26.68BUSDP/E 25.6
GH
Guardant Health, Inc.
$21.92BUSD
MEDP
Medpace Holdings, Inc.
$16.98BUSDP/E 35.8
ERF
Eurofins Scientific SE
$13.65BUSDP/E 25.3
CRL
Charles River Laboratories International, Inc.
$13.84BUSD
RVTY
Revvity Inc. Common Stock
$13.33BUSDP/E 57.4
BIM
bioMérieux S.A.
$9.55BUSDP/E 19.1

Key Statistics

Company
Market Cap5.94B $
Enterprise Value7.82B $
Revenue (TTM)2.27B $
Gross Profit235.49M $
Net Income (TTM)-18.65M $
Revenue/Share29.52 USD
Last Price76.28 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees11.0K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)86.90
PEG0.96
EV/EBITDA28.32
EV/Revenue3.45
P/S2.67
P/B5.60
EPS (TTM)-0.26
EPS (Forward)0.89
52W Range
50.8273% of range85.84
52W High85.84 USD
52W Low50.82 USD
Profitability
Gross Margin11.54%
Oper. Margin7.89%
EBITDA Margin12.17%
Profit Margin-0.91%
ROE-1.71%
ROA-0.50%
Growth
Revenue Growth25.00%
Earnings Growth-49.10%
Cash Flow & Leverage
Operating CF298.82M $
CapEx (TTM)213.25M $
FCF Margin6.95%
FCF Yield2.65%
Net Debt1.46B $
Net Debt/EBITDA5.28
Balance Sheet
Debt/Equity1.71
Current Ratio1.48
Quick Ratio1.39
Book Value/Sh13.76 USD
Cash/Share9.229 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:2
Split DateNov 28, 2006
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)92.88 USD
Upside (mean)+21.8%
Target Range65.00 USD – 105.00 USD
$65.00+21.8% to mean$105.00
# Analysts8
Ownership
Shares Out.78.70M
Float65.74M
Insiders9.96%
Institutions105.08%
Short Interest
Short Ratio13.9d
Short % Float15.68%
Short % Out.13.26%
Shares Short10.43M
Short (prev mo.)10.00M
Technical
SMA 5064.70 (+17.9%)
SMA 20066.19 (+15.2%)
Beta1.38
S&P 52W Chg18.16%
Avg Vol (30d)706.95K
Avg Vol (10d)790.42K
Technical Indicators
RSI (14)67.7
MACD4.0250
MACD Signal3.3965
MACD Hist.+0.6285
BB Upper81.94 USD
BB Middle68.78 USD
BB Lower55.62 USD
BB Width38.27%
ATR (14)2.945 USD
Vol Ratio (20d)0.49x